<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04767048</url>
  </required_header>
  <id_info>
    <org_study_id>2020-A00947-32</org_study_id>
    <nct_id>NCT04767048</nct_id>
  </id_info>
  <brief_title>Interest of Bilateral Basic Tongue Mucosectomy Assisted by Robot or Laser in Combination With Tonsillectomy in the Assessment of Prevalent Cervical Lymphadenopathy</brief_title>
  <acronym>RoboCUP</acronym>
  <official_title>Interest of Bilateral Basic Tongue Mucosectomy Assisted by Robot or Laser in Combination With Tonsillectomy in the Assessment of Prevalent Cervical Lymphadenopathy: a Randomized Phase II Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Francois Baclesse</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Francois Baclesse</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      We are proposing a randomized phase II study to assess the benefit of bilateral&#xD;
      robot-assisted or laser basal tongue mucosectomy in combination with tonsillectomy in the&#xD;
      assessment of prevalent cervical lymphadenopathy&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 30, 2021</start_date>
  <completion_date type="Anticipated">March 2025</completion_date>
  <primary_completion_date type="Anticipated">March 2025</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
    <masking_description>tonsillectomy +/- bilateral mucosectomy</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Detection of primary cancer</measure>
    <time_frame>At surgery</time_frame>
    <description>Proportion of patients with primary cancer detected with surgery</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">72</enrollment>
  <condition>Cancer of Head and Neck</condition>
  <condition>Adenopathy</condition>
  <arm_group>
    <arm_group_label>Experimental Arm</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Basic bilateral tongue mucosectomy assisted by robot or laser plus tonsillectomy (unilateral or bilateral at the choice of the investigator)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control Arm</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Tonsillectomy alone (unilateral or bilateral at the choice of the investigator)</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>bilateral mucosectomy + tonsillectomy</intervention_name>
    <description>Basic bilateral tongue mucosectomy assisted by robot or laser plus tonsillectomy (unilateral or bilateral at the choice of the investigator)</description>
    <arm_group_label>Experimental Arm</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>tonsillectomy</intervention_name>
    <description>tonsillectomy (unilateral or bilateral at the choice of the investigator)</description>
    <arm_group_label>Control Arm</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patient with a prevalent head and neck lymphadenopathy with positive or&#xD;
             non-contributory fine needle aspiration, or having had an adenectomy revealing a&#xD;
             metastasis of squamous cell carcinoma, a PET examination, an injected cervico-thoracic&#xD;
             CT and an ENT work-up (nasofibroscopy) not finding a primary tumor&#xD;
&#xD;
          -  Performance Status &lt; 2&#xD;
&#xD;
          -  Patient aged 18 or over&#xD;
&#xD;
          -  Patient affiliated with social security system&#xD;
&#xD;
          -  Informed consent signed&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  History of squamous cell carcinoma of the VADS or skin of the face.&#xD;
&#xD;
          -  History of cervico-facial radiotherapy&#xD;
&#xD;
          -  Primary tumor discovering during pan-endoscopy&#xD;
&#xD;
          -  Inexposable patient lead not to possible mucosectomy&#xD;
&#xD;
          -  Uncontrollable hemostasis disorders (contraindication to tonsillectomy and basic&#xD;
             bilateral mucosectomy of language)&#xD;
&#xD;
          -  Distant metastases&#xD;
&#xD;
          -  Lymphadenopathy inoperable&#xD;
&#xD;
          -  Patient with a contraindication to radiotherapy&#xD;
&#xD;
          -  Pregnant or breastfeeding woman&#xD;
&#xD;
          -  Women of childbearing potential without effective contraception&#xD;
&#xD;
          -  Patient under guardianship or unable to give informed consent&#xD;
&#xD;
          -  Patient unable to undergo the trial follow-up for geographic, social or&#xD;
             psychopathological reasons&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Vianney BASTIT, MD</last_name>
    <phone>33231455050</phone>
    <email>v.bastit@baclesse.unicancer.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Centre Fran√ßois Baclesse</name>
      <address>
        <city>Caen</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Vianney BASTIT, MD</last_name>
      <email>v.bastit@baclesse.unicancer.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>June 2021</verification_date>
  <study_first_submitted>February 19, 2021</study_first_submitted>
  <study_first_submitted_qc>February 22, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">February 23, 2021</study_first_posted>
  <last_update_submitted>June 30, 2021</last_update_submitted>
  <last_update_submitted_qc>June 30, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 2, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>mucosectomy</keyword>
  <keyword>tonsil</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Head and Neck Neoplasms</mesh_term>
    <mesh_term>Lymphadenopathy</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

